Evan David Seigerman
Stock Analyst at BMO Capital
(0.74)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NGNE Neurogene | Maintains: Outperform | 22 26 | 17.17 | 51.43% | 2 | Jun 12, 2025 | |
REGN Regeneron Pharmaceut... | Maintains: Outperform | 800 600 | 511.24 | 17.36% | 7 | Jun 2, 2025 | |
MRUS Merus | Maintains: Outperform | 96 110 | 52.67 | 108.85% | 1 | May 23, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Outperform | 24 28 | 22.34 | 25.34% | 1 | May 19, 2025 | |
ARVN Arvinas | Maintains: Outperform | 20 10 | 7.31 | 36.8% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 105 64 | 69.62 | -8.07% | 6 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 105 96 | 79.17 | 21.26% | 4 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 208 215 | 183.67 | 17.06% | 7 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 362 346 | 285.34 | 21.26% | 4 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 27 | 9.32 | 189.7% | 3 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 52 57 | n/a | n/a | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 83 100 | 21.14 | 373.04% | 2 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 33 36 | 23.89 | 50.69% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 31 72 | n/a | n/a | 4 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 3 | 4.59 | -34.64% | 1 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 369 396 | 770.14 | -48.58% | 1 | Sep 6, 2022 |